Status:
COMPLETED
The Effect of rTMS Treatment on Alzheimer's and Sleep Quality
Lead Sponsor:
Dr. Zahra Kazem-Moussavi
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
This research is being conducted to study whether rTMS (repetitive Transcranial Magnetic Stimulation) could be potentially used as a treatment for Alzheimer's disease. rTMS is a technique that stimula...
Detailed Description
Upon meeting the inclusion criteria and providing informed consent, each participant will complete a series of cognitive assessments and rTMS treatments at the TMS Lab at Riverview Health Center. Each...
Eligibility Criteria
Inclusion
- Individuals must have a MoCA score between 5 and 26, indicating mild cognitive impairment or dementia.
- Participants must have probable early or moderate Alzheimer's disease as confirmed by their treating neurologist or psychiatrist, and/or by the co-investigators.
Exclusion
- A recent (the last 3 months) history of stroke, recent (the last 3 months) head injury and loss of consciousness, any history of epilepsy, seizures, multiple sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), or Autism.
- Recent changes in medication (i.e. patients should be in a relatively stable phase of disease).
- The presence of metallic objects in the body; dental implants are fine but people with pacemakers are to be excluded; basically anything that is unsafe under MRI would be considered unsafe for TMS application.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01894620
Start Date
May 1 2013
End Date
October 1 2014
Last Update
February 24 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Misericordia Health Center
Winnipeg, Manitoba, Canada, R3C 1A2
2
Riverview Health Center
Winnipeg, Manitoba, Canada, R3L 2P4